← Blog

Treatment options

What Is Enclomiphene? A Science-Backed Guide for Men With Low Testosterone

2026-06-09 · 9 min read · Reviewed against peer-reviewed literature

The short version: Enclomiphene is an oral pill that nudges your body to make more of its own testosterone, instead of adding testosterone from outside the way a gel or injection does. In studies it brought testosterone up into the normal range while keeping fertility intact, something standard testosterone therapy usually does not.45 It has drawn real clinical interest, and in trials it has been generally well tolerated, but it is not FDA-approved and is used off-label.1 This is education, not medical advice or a diagnosis.

The problem it solves

Testosterone therapy (TRT) is the usual treatment for low testosterone, and it reliably raises your level. But it comes with a well-known catch.

Because TRT adds testosterone from outside, your body stops making its own, and that commonly shuts down sperm production.5 For a man who wants his testosterone back but also wants to stay fertile, that is the tension.

Enclomiphene drew attention because it goes at the problem from the other direction: it aims to raise testosterone by getting your own body to make more of it, which in trials kept fertility intact.157 That is why reproductive urologists and fertility doctors have spent the last decade studying it.

What it actually is

At its simplest, enclomiphene is a daily pill that tells your body to make more testosterone on its own.

The technical name is a selective estrogen receptor modulator (SERM), which means it blocks estrogen's signal in one specific place: the part of your brain that controls testosterone. The next section walks through how that works.1

Where clomiphene comes in. You will see "clomiphene" and "enclomiphene" used almost interchangeably, so here is the difference. Clomiphene (brand name Clomid) is the older drug, approved for women's fertility and used off-label in men for years. Each Clomid tablet is a mix of two mirror-image molecules, enclomiphene and zuclomiphene, with enclomiphene the larger share.6

Enclomiphene is the good half. It raises testosterone and clears your body within days. Zuclomiphene is the half that acts a little like estrogen, lingers for weeks, and gets blamed for most of clomiphene's side effects.6 So enclomiphene is that active half on its own: the older drug, cleaned up. When the two were compared head to head in 2024, enclomiphene raised testosterone at least as well, with a smaller estrogen bump and fewer side effects.2

How it works

Your body runs testosterone on a thermostat. Here is the loop, step by step:1

  1. Your brain watches your estrogen level and sends out two signals, LH and FSH, that tell your testicles to get to work.
  2. Enclomiphene blocks the estrogen signal in your brain, so your brain reads estrogen as low.
  3. To compensate, your brain sends out more LH and FSH.
  4. More LH means your testicles make more testosterone, using your own machinery.

That last part is the whole point. Enclomiphene works through your own system instead of overriding it, which is the opposite of how a testosterone gel or injection works.3

Enclomiphene vs TRT

This is the part that gets men's attention. Testosterone therapy and enclomiphene can both get your number up, but they do it in opposite ways, and the differences that matter most to a lot of men come straight out of that.

 EnclomipheneTestosterone (TRT)
How it worksPrompts your body to produce testosteroneReplaces testosterone from an external source
Fertility signals (LH/FSH)Increase5Suppressed
Sperm productionPreserved in trials45Commonly suppressed
RouteOral pillInjection, gel, or patch
FDA statusNot approved (off-label / compounded)1FDA-approved

In head-to-head trials, enclomiphene and a testosterone gel raised total testosterone to similar levels. The difference was in the fertility signals: only enclomiphene also kept LH, FSH, and sperm production up.35

For a man who wants his testosterone back without giving up fertility or committing to lifelong injections, that combination is the appeal. It is also why researchers kept studying it instead of settling for gel, and why newer work has kept pointing the same way.7

Who it fits, and who it doesn't

Enclomiphene is studied for one specific situation: secondary hypogonadism. That is when your testicles still work fine, but your brain is not sending a strong enough signal.67

It tends to make sense when:

  • Your testosterone is confirmed low on two morning blood tests, and you have symptoms.9
  • Your LH and FSH are low or normal, pointing to a signaling problem rather than damaged testicles.
  • You want to protect your fertility. For younger men, this is often the deciding factor.7
  • You would rather take a daily pill than do injections or gels.

It is a poor fit when the testicles themselves are damaged (primary hypogonadism), because the drug needs working testicles to push.6 Sorting out which kind you have is a clinician's job, not something a website or a quiz can decide for you.

What to expect

If a clinician does prescribe it, here is the rough shape of what the research describes. Your own protocol is up to your doctor.

  • Timing. Testosterone starts rising in the first weeks of treatment. In the dose-finding trial, men on the higher dose reached the normal range by about six weeks.4
  • The numbers. A Phase II trial brought average testosterone to about 604 ng/dL, squarely in the normal range and on par with a gel.4 A 2025 review pooling the randomized trials put the average gain near 274 ng/dL over placebo.8
  • Fertility. Across the trials, sperm production held steady, the opposite of what testosterone therapy tends to do.5

One honest caveat worth keeping in mind: most of these trials are short (weeks to months) and fairly small. The long-term picture, beyond a year or two, is not fully mapped yet. A testosterone rise is a good sign, but it is not the same as proof of long-term health benefits.8

The honest trade-offs

Every medicine carries some risk. So do supplements, vitamins, and the over-the-counter pills in your cabinet. The useful question is never "is there any risk," it is "how big, and compared to what." By that standard, enclomiphene's reported side effects are mostly mild, and in the head-to-head comparison it was better tolerated than older clomiphene, with far fewer side effects overall.2

What gets reported:

  • Headache or mild stomach upset. Occasional and usually short-lived.
  • Estrogen (estradiol) changes. Usually mild here. Because enclomiphene blocks estrogen signaling, estradiol tends to stay flat or dip slightly, and the 2024 comparison even found a small decrease.2 In some men it can tick up, since extra testosterone gives the body more to convert into estrogen. If it ran high, estrogen in men is linked to breast tenderness and water retention, which is why doctors keep an eye on it and adjust the dose.6
  • Visual changes. Rare, and more tied to clomiphene than enclomiphene.
  • Mood changes. Reported less often than with clomiphene.2

One thing it does not seem to do, unlike testosterone therapy, is shut down sperm production.5 A doctor will usually track your testosterone, LH/FSH, estradiol, blood thickness (hematocrit), and cholesterol along the way.

The big asterisk: it is not FDA-approved. Enclomiphene is prescribed off-label, usually through a compounding pharmacy, because it is part of approved clomiphene.17 Its maker once sought approval, but regulators did not accept a testosterone rise by itself as proof of benefit, and the follow-up trials were never finished.6 Off-label use is common and legal across medicine (many everyday drugs are used this way). It means the drug never went through a full FDA approval for this exact use, which is worth understanding, not a verdict that it is unsafe.

Lifestyle still matters

Any hormone treatment is one piece of a bigger picture, and the basics still move your testosterone on their own: resistance training, 7 to 9 hours of sleep, dropping excess body fat, managing stress, and going easy on alcohol. Several of those also fix the reversible causes of low testosterone in the first place.6

The bigger debate, in plain English

You will run into two camps when you read about enclomiphene, and it helps to know who is talking.

Conventional doctors (most endocrinologists and many urologists) lean cautious. They like the data but point out that the trials are short, the long-term safety is not proven, and the drug is not approved. A well-known 2017 paper argued for fixing sleep, weight, and other health issues first, before reaching for an off-label drug.10

Functional and integrative doctors (a style of medicine focused on root causes and "optimizing" rather than only treating disease, common in men's-health and age-management clinics) tend to be more enthusiastic. Their case, in plain terms:

  • Restore, don't replace. They like that enclomiphene restarts your own production instead of taking it over.13
  • Keep fertility on the table, which is why they often reach for it first in younger men.5
  • A reset, not a life sentence. Some use it as a 6-to-9-month course hoping to reset the system, though the trials were not built to prove that sticks.
  • Treat the man, not just the cutoff, leaning on the argument that a single 300 ng/dL line can under-call younger men, whose normal range tends to run higher (more on the research timeline).

Neither camp is simply right. The same trials support a real, fertility-sparing option and still leave open questions, which is exactly why this belongs in a conversation with a clinician who knows your labs and goals. If you want to hear these people in their own words, we gather credible voices on our who to follow page, and lay both readings side by side on the research timeline.

What to do next

If this sounds like it might fit you, the next step is not a prescription, it is a clear picture. Bring these to a doctor and you will have a much better conversation:9

  • Two morning testosterone tests (before 10 AM). A diagnosis needs more than one reading.
  • A short note on your symptoms: energy, sex drive, mood, sleep.
  • A question about your LH and FSH, which point to whether the cause is your brain's signal or your testicles.
  • Your fertility plans. They genuinely change which treatment makes sense.
  • A question about all your options, including oral and fertility-sparing ones, before you commit to anything.

The goal is simple: understand your own body well enough to make a calm, informed choice with someone qualified to guide it.

Think enclomiphene might be a fit for you?

The honest answer depends on your labs, your symptoms, and whether the cause is a signaling problem or something else, which is exactly what a clinician sorts out. Veedma's free assessment reviews your situation and tells you whether you're even a candidate, with no obligation.

Take Veedma's free assessment

Educational only. Not medical advice, not a diagnosis, and not a recommendation to take any specific medication. Enclomiphene is not FDA-approved and is used off-label. Any treatment decision is made with a licensed clinician.

Sources

  1. Earl JA, Kim ED. Enclomiphene citrate: a treatment that maintains fertility in men with secondary hypogonadism. Expert Rev Endocrinol Metab. 2019;14(3):157–165. PubMed
  2. Saffati G, et al. A comparison of enclomiphene and clomiphene citrate for the treatment of hypogonadism. Transl Androl Urol. 2024;13(9):1984–1990. PubMed
  3. Kaminetsky J, et al. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone. J Sex Med. 2013;10(6):1628–1635. PubMed
  4. Wiehle R, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a Phase II study. BJU Int. 2013;112(8):1188–1200. PubMed
  5. Wiehle RD, et al. Enclomiphene citrate preserves sperm counts compared with topical testosterone (Phase II RCTs). Fertil Steril. 2014;102(3):720–727. PubMed
  6. Rodriguez KM, Pastuszak AW, Lipshultz LI. Enclomiphene citrate for the treatment of secondary male hypogonadism. Expert Opin Pharmacother. 2016;17(11):1561–1567. PubMed
  7. Earl JA, Kim ED. (Review of clomiphene/enclomiphene FDA status and off-label use in men.) Expert Rev Endocrinol Metab. 2019;14(3):157–165. PubMed
  8. Hohl A, et al. Selective estrogen receptor modulators for male hypogonadism: a systematic review and meta-analysis. Arch Endocrinol Metab. 2025;69(5):e250093. PubMed
  9. Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. PubMed
  10. Grossmann M, Matsumoto AM. A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management. J Clin Endocrinol Metab. 2017;102(3):1067–1075. PubMed